Type 2 Diabetes Mellitus and COVID-19: A Narrative Review

The pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than one hundred million individuals, including more than two million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrao, Salvatore, Pinelli, Karen, Vacca, Martina, Raspanti, Massimo, Argano, Christiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044543/
https://www.ncbi.nlm.nih.gov/pubmed/33868163
http://dx.doi.org/10.3389/fendo.2021.609470
_version_ 1783678509637435392
author Corrao, Salvatore
Pinelli, Karen
Vacca, Martina
Raspanti, Massimo
Argano, Christiano
author_facet Corrao, Salvatore
Pinelli, Karen
Vacca, Martina
Raspanti, Massimo
Argano, Christiano
author_sort Corrao, Salvatore
collection PubMed
description The pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than one hundred million individuals, including more than two million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in COVID-19 patients. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient.
format Online
Article
Text
id pubmed-8044543
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80445432021-04-15 Type 2 Diabetes Mellitus and COVID-19: A Narrative Review Corrao, Salvatore Pinelli, Karen Vacca, Martina Raspanti, Massimo Argano, Christiano Front Endocrinol (Lausanne) Endocrinology The pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than one hundred million individuals, including more than two million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in COVID-19 patients. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient. Frontiers Media S.A. 2021-03-31 /pmc/articles/PMC8044543/ /pubmed/33868163 http://dx.doi.org/10.3389/fendo.2021.609470 Text en Copyright © 2021 Corrao, Pinelli, Vacca, Raspanti and Argano https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Corrao, Salvatore
Pinelli, Karen
Vacca, Martina
Raspanti, Massimo
Argano, Christiano
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
title Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
title_full Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
title_fullStr Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
title_full_unstemmed Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
title_short Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
title_sort type 2 diabetes mellitus and covid-19: a narrative review
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044543/
https://www.ncbi.nlm.nih.gov/pubmed/33868163
http://dx.doi.org/10.3389/fendo.2021.609470
work_keys_str_mv AT corraosalvatore type2diabetesmellitusandcovid19anarrativereview
AT pinellikaren type2diabetesmellitusandcovid19anarrativereview
AT vaccamartina type2diabetesmellitusandcovid19anarrativereview
AT raspantimassimo type2diabetesmellitusandcovid19anarrativereview
AT arganochristiano type2diabetesmellitusandcovid19anarrativereview

Ejemplares similares